Composition of angiotensin-II receptor antagonists and calcium c

Details Composition of angiotensin-II receptor antagonists and calcium c Composition of angiotensin-II receptor antagonists and calcium c

1994-07-28

1996-02-20

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514381, 514929, A61K 3155, A61K 3141

Patent

active

054929040

ABSTRACT:
Novel pharmaceutical compositions containing a combination of an angiotensin-II antagonist and a calcium channel blocker such as 2-butyl-4 chloro-1-[2-(1-H-tetrazol-5-yl)biphenyl-4-yl)methyl]-5-(hydroxymethyl) imidazole, and diltiazem and the use of such compositions in the treatment of hypertension and congestive heart failure.

REFERENCES:
patent: 4983598 (1991-01-01), Caver et al.
CA 109(15):129008g, Carini et al., 1988.
CA 112(13):118817f, Carini et al., 1989.

Affiliated with

Also associated with

Rating

Composition of angiotensin-II receptor antagonists and calcium c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition of angiotensin-II receptor antagonists and calcium c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of angiotensin-II receptor antagonists and calcium c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1355989